Winship faculty, clinicians and fellows will lead sessions and present important new findings at the 48th San Antonio Breast Cancer Symposium (#SABCS25) in San Antonio, Dec. 9-12, 2025. ⬇️ brnw.ch/21wYdCL

Announcing the Academy’s 2025 Gold Medal recipient, Dr. Lewin, MD, FACR! 🏅 This prestigious award recognizes extraordinary contributions to advancing imaging and radiology research. Click the link to learn more www.acadrad.org/wp-content/u.... @emoryradiology.bsky.social @winshipcancer.emory.edu

We’re celebrating one year of Winship’s HDR brachytherapy program at Emory Midtown! 🎉 Since its launch, the program has expanded access to advanced, image-guided cancer care in a state-of-the-art operative suite. Read more ➡️ brnw.ch/21wW3Jm

🎉 Winship, through generous support from the Arthur M. Blank Family Foundation and in collaboration with Mount Sinai Health System, celebrated the launch of the new Winship Mobile Prostate Cancer Screening Program today at a community event inside Mercedes-Benz Stadium. ➡️ brnw.ch/21wVpyk

Winship epidemiologist Michael Goodman, MD, MPH, collaborates with India’s Center for Chronic Disease Control to strengthen cancer surveillance systems and improve how cases are tracked. Read more ➡️ brnw.ch/21wV7KI

Winship investigators have been awarded a total of $400,000 to support eight new projects through Winship Invest$, a peer-reviewed program designed to accelerate innovative cancer research. Learn more ➡️ brnw.ch/21wUWPO

FDA Approval of Mirdametinib Reduces Treatment Barriers for Adult Patients With NF1-Associated PNs @winshipcancer.emory.edu #oncology www.onclive.com/view/fda-app...

One of the biggest challenges in cancer care is when patients stop responding to treatment. A new study led by Mourad Zerfaoui, PhD, reveals how loss of a molecule called AHR fuels drug resistance in BRAF-mutant melanoma and thyroid cancer. 🔗 brnw.ch/21wUGp7

www.v.org/grants/chrys... Honored to be awarded the All-Star V Foundation grant! Inspired by great team efforts between #Paulos and #Lesinski labs! Props to cell therapy gurus @megen-w.bsky.social #AnnaCole @meganmw.bsky.social and crew @winshipcancer.emory.edu

That wraps up the first segment of the lymphoma session at #DDHO2025, closing with a patient-centered panel discussion featuring EHA highlights and a dynamic Q&A.

Day 2 of #DDHO2025 is underway, kicking off with the first lymphoma session.

Debate: early vs delayed transplantation in myelofibrosis Amelia Langston, MD argues for early ☀️ Michael Hochman, MD argues for delayed ⏰ #DDHO2025

Are ADCs Highly Promising for the Treatment of NSCLC...or... ADCs are the Futures of NSCLC? Winship’s Conor E. Steuer, MD argues yes! #DDHO2025

Winship executive director Suresh Ramalingam, MD, and Winship chief medical officer Sagar Lonial, MD, kick off this year’s #DDHO2025 🎉

Kicking off #DDHO25 👏

Jill Barnholtz-Sloan Has Been Appointed Chief Administrative Officer and Associate Director at Winship Cancer Institute @winshipcancer.emory.edu oncodaily.com/career/jill-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Winship urologist Vikram Narayan, MD, FACS, was profiled by Apple for Emory Healthcare's use of Apple technology to streamline workflows and enhance patient care. 🎥 Read more and Watch the video ➡️ brnw.ch/21wUcrF

Winship thoracic oncologist Fatemeh Ardeshir, MD, MSc. commented on the new FDA-approved treatment option, Datroway (datopotamab deruxtecan or Dato-DXd). The treatment is now available for people with non-small cell lung cancer (NSCLC) who harbor a common EGFR mutation. Learn more: brnw.ch/21wUbRP

🎗️ July is Sarcoma Awareness Month. Sarcomas are rare cancers—making up less than 1% of adult cases—with 150+ types that require expert care. Sarcoma expert Kenneth Cardona, MD, FACS, says their rarity makes diagnosis and treatment especially challenging. Learn more ➡️ brnw.ch/21wU8tY

🎉Seventy-three Winship physicians were selected by their peers as "Top Doctors" for Atlanta magazine's 2025 list of the city's best doctors.

Check out our new paper in Hepatology on how myeloid cells limit immunotherapy in preclinical cholangiocarcinoma models! Disease site matters! @chrystalpaulos.bsky.social @megen-w.bsky.social @winshipcancer.emory.edu many others! pubmed.ncbi.nlm.nih.gov/40590857/

Neil Iyengar joins @winshipcancer.emory.edu‬ as survivorship director, co-director of Breast Oncology Program https://cancerletter.com/in-brief/20250703_7a/

🎊Joining Winship on July 1, breast medical oncologist and cancer survivorship expert Neil M. Iyengar, MD, has been appointed director of survivorship services at Winship Cancer Institute of Emory University. Read more ➡️ brnw.ch/21wTPea

Winship medical oncologist Kevin Kalinsky, MD, MS, FASCO, discusses how findings from the phase 3 SERENA-6 trial reinforce the importance of timely ESR1 testing in HR-positive breast cancer. Read more ➡️ brnw.ch/21wTOyy

“Can I take this supplement?” It’s a common question after a cancer diagnosis—but it’s just one part of a bigger picture. At Winship, Naturopathic Doctor serving as an Integrative Oncology Specialist Anna Bausum, ND, FABNO, helps patients build a strong foundation to support healing. brnw.ch/21wTN9a

🔬 Can AI paint a fuller picture of cancer? Winship researchers, including Anant Madabhushi, PhD, and Nabil F. Saba, MD, FACP, are using AI to combine CT scans, tissue slides and epigenetic data to better predict cancer outcomes—especially for head and neck cancers. ➡️ brnw.ch/21wTHzS

🎙️Your voice says a lot—sometimes even signals cancer. Winship researcher Anthony Law, MD, PhD is using AI to help primary care doctors detect signs of laryngeal cancer through voice changes—something specialists are trained to hear but others might miss. ➡️ brnw.ch/21wTCiL

Emory hematology and medical oncology fellows Michelle Lee, MD, PhD, and Kingsley Nnawuba, MD, were recognized with @conquercancer.bsky.social ‪awards at the #ASCO25 Annual Meeting. Lee received a Young Investigator Award, and Nnawuba received a Research Award. 👏👏👏

Launched in 2023, Winship's Oncology Nurse Residency Program is designed to provide new nurses with foundational knowledge, practical experience and mentorship to confidently transition to the specialized field of oncology. Learn more 👉 winshipcancer.emory.edu/newsroom/art...

Curiosity and Compassion Propel Lung Cancer Pioneer Ramalingam to TIME100 Health 2025 List @ramalingammd.bsky.social @winshipcancer.emory.edu #LungCancer www.onclive.com/view/curiosi...

🎉 It’s a wrap on #ASCO25! Winship was proud to have a strong presence this year with our booth! 💙🏢🙌 🙏 Thanks to everyone who stopped by to connect with us! 💬💙

Winship breast oncologist Jane Meisel, MD, summarizes yesterday’s #ASCO25 plenary session of the SERENA-6 trial results showing the benefit of using circulating tumor DNA (ctDNA) monitoring to guide treatment changes for patients with HR+/HER2- advanced #breastcancer.

Winship medical oncologist Jacqueline Brown, MD, gives a summary of an abstract discussion she moderated at #ASCO25 on new treatment directions in advanced #bladdercancer.

Emory postdoc Sahar Almahfouz Nasser, PhD, and doctoral student Satvika Bharadwaj, MS, presented posters this morning incorporating the use of tools like computational pathology and artificial intelligence #AI in breast cancer research. #ASCO25

Winship medical oncologist Jacob Berchuck, MD, shares a brief summary of a study, “Plasma epigenomic profiling to reveal molecular correlates of response and resistance to 177Lu-PSMA-617 in metastatic castration-resistant #prostatecancer” from today’s #ASCO25 poster session.

Emory hematology and medical oncology fellow Maroun Bou Zerdan, MD, is presenting his work, “Prognostic relevance of Aurora kinase A (AURKA) expression in prostate cancer” in this morning’s #ASCO25 poster session.

Good morning from Chicago! 📣 Winship at #ASCO25 Monday Sessions 📣 View Full Schedule ➡️ brnw.ch/21wT5xe

Winship medical director of the clinical trials office and a leading lung cancer expert Ticiana Leal, MD discusses the abstracts she presented earlier today at #ASCO25!

Winship surgical oncologist and #sarcoma expert Ken Cardona, MD, talks about how #ASCO25 provides clinicians and investigators the opportunity to come together and advance the field forward for sarcoma and other rare cancers.

Winship Executive Director Suresh Ramalingam, MD, stopped by the Winship booth at #ASCO25 to tell us what excites him about this year’s annual meeting and highlights the work behind our research that becomes hope for patients with cancer.

Winship radiation oncologist Zachary Buchwald, MD, PhD, provides a brief description of a fascinating clinical trial evaluating how time-of-day–specified immunotherapy for patients with advanced melanoma affects their outcome. #ASCO25

Winship SVP of Cancer Nursing Colleen Lewis, MSN, ANP-BC, AOCNP, stopped by our #ASCO25 booth to share insights on the growing role of patient navigation in cancer care.

Winship breast oncologist Kevin Kalinsky, MD, MS, presented an oral abstract on the “Efficacy and safety of ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in NATALEE” this morning. #ASCO25

📣 Good morning! Day 3 is underway at the 2025 American Society of Clinical Oncology Annual Meeting in Chicago. Find a full listing of presentations with Winship experts here. #ASCO25 👉 brnw.ch/21wSZut

Winship CMO and #multiplemyeloma expert Sagar Lonial, MD, stopped by our booth to let us know what he is looking forward to at this year’s #ASCO25.

Winship thoracic oncologists and researchers Jennifer Carlisle, MD, and Fatemeh Ardeshir, MD, presented their work during today’s afternoon poster session. Dr. Carlisle discussed the use of tarlatamab for SCLC in the outpatient setting and Dr. Ardeshir covered ctDNA in young-onset NSCLC. #ASCO25

Radiation oncologist Patricia Santos, MD, MS, @trishasantos.bsky.social shares insights on her poster highlighting “Access to cancer care for undocumented immigrants in the United States.” #ASCO25

Don’t forget to come check out Winship at #ASCO25 at booth 10000 from 9-5pm!

Congratulations to Sagar Lonial, MD, Jane Meisel, MD and Kevin Kalinsky, MD, MS, for being named fellows of @asco They received their awards today during a presentation at #ASCO25. 🏅

📣 It’s day two at the 2025 American Society of Clinical Oncology #ASCO25 Annual Meeting in Chicago. Find a full listing of presentations with Winship experts here. 👉 brnw.ch/21wSZut